Compounds That Target BMX

BMX non-receptor tyrosine kinase · 25 compounds in BiohacksAI corpus

BMX (BMX non-receptor tyrosine kinase) is a biological target with 25 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into BMX modulation for therapeutic and biohacking applications.

View BMX target page →UniProt: P51813 ↗

Most Studied Compounds for BMX

Crizotinib

298+

studies

Bdb Pf 06651600 Us11111242 Example 5 Us9617258 Example 5

studies

All 25 Compounds — Ranked by Evidence

Ibrutinib

4.86

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Bosutinib

4.08

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Mln 8054

3.33

confidence

Acalabrutinib

3.22

confidence

Jnj 7706621

3.09

confidence

Lestaurtinib

3.04

confidence

Spebrutinib

3.04

confidence

R 406

2.83

confidence

Infigratinib

2.77

confidence

Ritlecitinib

2.77

confidence

Kw 2449

2.64

confidence

Ast 487

2.56

confidence

Zanubrutinib

2.56

confidence

Evobrutinib

2.48

confidence

Rebastinib

2.20

confidence

Tirabrutinib

1.95

confidence

Anilinopyrimidine1

1.79

confidence

Crizotinib

298+

studies

0.69

confidence

Bdb Pf 06651600 Us11111242 Example 5 Us9617258 Example 5

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for BMX (BMX non-receptor tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: BMX target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.